Martek Biosciences Corporation
Company Balance Sheet
| Oct 2007 | Oct 2006 | Oct 2005 | Oct 2004 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 16.97M | 15.58M | 11.05M | 29.44M |
| Receivables | 41.64M | 32.75M | 27.60M | 37.29M |
| Inventories | 109.41M | 100.32M | 91.54M | 30.38M |
| Other Current Assets | 8.24M | 10.07M | 5.93M | 6.79M |
| Total Current Assets | 195.49M | 169.97M | 158.41M | 117.11M |
| Property, Plant & Equipment, Gross | 348.37M | 321.12M | 317.50M | 276.02M |
| Accumulated Depreciation & Depletion | 70.46M | 29.67M | 26.76M | 20.59M |
| Property, Plant & Equipment, Net | 277.92M | 291.44M | 290.73M | 255.43M |
| Intangibles | 34.32M | 36.83M | 79.62M | 78.17M |
| Other Non-Current Assets | 653.00K | 14.03M | 1.52M | 1.31M |
| Total Non-Current Assets | 401.21M | 430.88M | 420.07M | 384.28M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 596.70M | 600.85M | 578.48M | 501.40M |
| Accounts Payable | 18.12M | 21.66M | 16.66M | 28.90M |
| Short Term Debt | 0.00 | 1.23M | 0.00 | 2.03M |
| Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Liabilities | 46.14M | 49.79M | 34.21M | 48.92M |
| Long Term Debt | 9.31M | 46.28M | 66.12M | 97.18M |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 9.52M | 9.34M | 8.96M | 9.14M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 18.83M | 55.61M | 75.07M | 106.32M |
| Total Liabilities | 64.97M | 105.40M | 109.28M | 155.23M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 531.73M | 495.45M | 469.20M | 346.16M |
| Common Par | 3.23M | 3.22M | 3.20M | 2.95M |
| Additional Paid In Capital | 530.58M | 523.49M | 515.24M | 407.67M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -2.28M | -31.42M | -49.24M | -64.52M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 203.00K | 171.00K | 1.00K | 68.00K |
| Total Capitalization | 541.04M | 541.72M | 535.32M | 443.34M |
| Total Equity | 531.73M | 495.45M | 469.20M | 346.16M |
| Total Liabilities & Stock Equity | 596.70M | 600.85M | 578.48M | 501.40M |
| Total Common Shares Outstanding | 32.34M | 32.16M | 32.03M | 29.49M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 32.34M | 32.11M | 31.16M | 29.03M |
| Diluted Weighted Shares Outstanding | 32.59M | 32.34M | 32.03M | 30.39M |
| Number of Employees | 515 | 506 | 582 | 541 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Quotes
News & Commentary
Financials
Company Information
Ratings
Find more premium investing ideas